Press Release: Actelion to host an investor event at American College of Cardiology (ACC.15)

   (MORE TO FOLLOW) Dow Jones Newswires

   March 09, 2015 12:35 ET (16:35 GMT)- - 12 35 PM EDT 03-09-15

-2 of 2- 09 Mar 2015 16:35:00 UTC  Press Release: Actelion to host an investor event at American College of Cardiology (ACC.15)

Actelion Pharmaceuticals Ltd / Actelion to host an investor event at American College of Cardiology (ACC.15) . Processed and transmitted by NASDAQ OMX Corporate Solutions. The issuer is solely responsible for the content of this announcement.

Dear member of the investment community

Following the presentation 'Effect of selexipag on morbidity/mortality in pulmonary arterial hypertension: results of the GRIPHON study' by Vallerie V. McLaughlin on March 15, 2015 at 12:00 p.m. PDT, Actelion will host an investor event at American College of Cardiology (ACC.15).

This event is by invitation only for covering buy- and sell-side analysts as well as institutional investors.

If you wish to attend, please contact: investor.relations@actelion.com

Meeting Information

15 March 2015

6.00 - 8.30 p.m. Pacific Daylight Time

Venue

Hard Rock Hotel

207 5th Avenue

San Diego, CA 92101

Highlights

Oral presentation entitled 'Effect of selexipag on morbidity/mortality in pulmonary arterial hypertension: results of the GRIPHON study'.

Invitation PDF: http://hugin.info/131801/R/1900510/675580.pdf

This announcement is distributed by Nasdaq OMX Corporate Solutions on behalf of NASDAQ OMX Corporate Solutions clients.

The issuer of this announcement warrants that they are solely responsible for the content, accuracy and originality of the information contained therein.

Source: Actelion Pharmaceuticals Ltd via Globenewswire

HUG#1900510

--- End of Message ---

Actelion Pharmaceuticals Ltd

Gewerbestrasse 16 Allschwil Switzerland

ISIN: CH0010532478;

http://www.actelion.com (END) Dow Jones Newswires

   March 09, 2015 12:35 ET (16:35 GMT)- - 12 35 PM EDT 03-09-15